The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a "moral imperative" to address hereditary diseases.
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a "moral imperative" to address hereditary diseases.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a "moral imperative" to address hereditary diseases.
Open the app view to save this story, compare related coverage, and continue from the same source.